🇺🇸 FDA
Pipeline program

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002)

MK-3214-002

Phase 1 other active

Quick answer

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002) for Hypercholesterolaemia is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).

Program details

Company
Merck Sharp and Dohme
Indication
Hypercholesterolaemia
Phase
Phase 1
Modality
other
Status
active

Clinical trials